The American Association for Cancer Research (AACR) publishes 10 highly regarded peer-reviewed journals that cover the continuum of cancer research. Earlier this year, two of those journals announced new editors-in-chief.
- Elizabeth M. Jaffee, MD, FAACR, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; and Antoni Ribas, MD, PhD, FAACR, of the University of California Los Angeles, were named the editors-in-chief of Cancer Immunology Research.
- Ross Levine, MD, FAACR, of Memorial Sloan Kettering Cancer Center, was appointed editor-in-chief of Blood Cancer Discovery.
Additionally, more than 30 oral and poster presentations at the AACR Annual Meeting 2026 will be simultaneously published as articles in AACR journals, reflecting the high number of laudable abstracts submitted for presentation at the meeting. Some of the studies are listed below, by day with session/presentation details, and will be concurrently published in the AACR journals noted. Direct links to the journal articles will be available here as they are published.
Friday, April 17
Oral Presentations
Novel NK cell approaches to cancer immunotherapy
Session: ED24: NK Cell-Based Cancer Immunotherapy: From Biology to the Clinic
Time: 3-4:30 p.m. PT
Location: Room 17 – Mezzanine Level – Convention Center
Journal: Blood Cancer Discovery
Saturday, April 18
Oral Presentations
AI transformation of pharmaceutical R&D
Session: ED04: AI in Biomarker Discovery and Drug Development
Time: 12:30-2 p.m. PT
Location: Ballroom 20 AB – Upper Level – Convention Center
Journal: Cancer Discovery
Sunday, April 19
Poster Presentations
PlasmaCHORD – A machine learning method for identifying clonal hematopoiesis variants in liquid biopsies
Session: PO.BCS01.11: Liquid Biopsy: Multi-Analyte and Multi-Omic
Time: 2-5 p.m. PT
Location: Section 5
Journal: Clinical Cancer Research
Cancer treatment-related cardiotoxicity among survivors of childhood cancer: A comparative and integrated view of multiple measures of biological age acceleration
Session: PO.PS01.10: Survivorship Research
Time: 2-5 p.m. PT
Location: Section 34
Journal: Cancer Epidemiology, Biomarkers & Prevention
Monday, April 20
Oral Presentations
Leveraging genetic diversity to improve knowledge and survival in acute myeloid leukemia
Session: AHM02: Population Sciences for Hematological Malignancies
Time: 12:30-2 p.m. PT
Location: Room 17 – Mezzanine Level – Convention Center
Journal: Blood Cancer Discovery
Towards fast and accessible precision oncology
Session: AT05: Using AI and Spatial Transcriptomics Data to Predict Spatial Gene Expression from Histopathology Slides
Time: 12:30-2 p.m. PT
Location: Ballroom 6 DE – Upper Level – Convention Center
Journal: Cancer Discovery
Autocrine LIF signaling: A novel therapeutic target to eliminate inflammatory and immunosuppressive cancer stem cells in LKB1 mutant lung adenocarcinoma
Session: SY26: Signaling Pathways in Cancer: Dedicated to the Memory of J. Michael Bishop
Time: 12:30-2 p.m. PT
Location: Room 30 – Upper Level – Convention Center
Journal: Cancer Discovery
Poster Presentations
Prolonged KRAS-MAPK inhibition activates interferon signaling to promote cellular plasticity and uncover novel targets for combination therapy
Session: PO.ET03.08: Targeting Drug Resistance 2: RAS Signaling
Time: 9 a.m.-12 p.m. PT
Location: Section 19
Journal: Cancer Research
Mechanisms of acquired resistance following dual EGFR/MET inhibition in MET-amplified EGFR TKI-resistant lung cancer
Session: LBPO.ET02: Late-Breaking Research: Experimental and Molecular Therapeutics 2
Time: 2-5 p.m. PT
Location: Section 53
Journal: Molecular Cancer Therapeutics
Single-cell transcriptomic insights into tumor and immune dynamics driving resistance to ixazomib combined with gemcitabine and doxorubicin in SMARCB1-deficient renal medullary carcinoma
Session: PO.TB10.03: Microenvironmental Determinants of Therapy Response and Resistance 1
Time: 2-5 p.m. PT
Location: Section 29
Journal: Clinical Cancer Research
Capturing Latino health disparities: Lessons from mail and community-based population health surveys in California
Session: PO.SHP01.01: Science and Health Policy 1
Time: 2-5 p.m. PT
Location: Section 39
Journal: Cancer Research Communications
Prognostic and predictive value of the Clearseq1-4 tumor microenvironment classification in localized and metastatic clear-cell renal cell carcinoma
Session: PO.CL12.01: Molecular Classification and Tumor Biology in Cancer
Time: 2-5 p.m. PT
Location: Section 46
Journal: Cancer Research Communications
Tuesday, April 21
Oral Presentations
Inhibition of DNA mismatch repair for therapeutic purposes
Session: SY16: Dharma Master Jiantai Symposium in Targeted Therapy: Immunotherapy and DNA Repair
Time: 12:30-2 p.m. PT
Location: Ballroom 6 B – Upper Level – Convention Center
Journal: Cancer Discovery
Early detection and interception of pancreatic cancer
Session: AOS10: Turning the Tide in the Fight Against Pancreatic Cancer
Time: 12:30-2 p.m. PT
Location: Ballroom 6 A – Upper Level – Convention Center
Journal: Cancer Discovery
RNA processing regulation of anti-tumor immune responses
Session: SY25: RNA Biology in Cancer: Dedicated to the Memory of David Baltimore
Time: 12:30-2 p.m. PT
Location: Room 29 – Upper Level – Convention Center
Journal: Blood Cancer Discovery
Poster Presentations
PRMT5 inhibitor SCR-6920 downregulates HIF-1α and exhibits synergistic antitumor activity with Bevacizumab
Session: PO.CH01.03: New Ligands and Inhibitors
Time: 9 a.m.-12 p.m. PT
Location: Section 38
Journal: Molecular Cancer Therapeutics
Turning cold tumors hot: Targeted TNF potentiates the activity of bispecific T cell engagers in solid tumors
Session: LBPO.IM03: Late-Breaking Research: Immunology 3
Time: 9 a.m.-12 p.m. PT
Location: Section 53
Journal: Cancer Immunology Research
scSurvival: Single-cell survival analysis of clinical cancer cohort data at cellular resolution
Session: PO.BCS01.12: New Software Tools for Data Analysis
Time: 2-5 p.m. PT
Location: Section 4
Journal: Cancer Discovery
Associations between perceived costs and rewards of sun protection and sun safety practices among high school students
Session: LBPO.PS01: Late-Breaking Research: Population Sciences
Time: 2-5 p.m. PT
Location: Section 55
Journal: Cancer Epidemiology, Biomarkers & Prevention
Advanced dual payload antibody-drug conjugates for targeted chemoimmunotherapy
Session: PO.IM01.09: T-Cell Engagers 2 / Antibody-Drug Conjugates 1
Time: 2-5 p.m. PT
Location: Section 8
Journal: Cancer Research Communications
Wednesday, April 22
Poster Presentations
Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T-cell phenotypes in CLL patients treated with ibrutinib
Session: PO.MCB08.05: Genomic Approaches to Define Tumor Biology and Clinical Stratification
Time: 9 a.m.-12 p.m. PT
Location: Section 21
Journal: Clinical Cancer Research
Ciliated cells drive critical STING-mediated tumor suppression in fallopian tube epithelium
Session: PO.PR02.02: Cancer and Cancer Related Alterations, Detection Approaches, and Molecular Characterization
Time: 9 a.m.-12 p.m. PT
Location: Section 36
Journal: Cancer Research
QW-5-70 targets the colchicine site to overcome multidrug resistance and shows potent antitumor activities
Session: PO.ET03.03: Novel Strategies to Reverse Drug Resistance
Time: 9 a.m.-12 p.m. PT
Location: Section 14
Journal: Molecular Cancer Therapeutics
Register Today for the AACR Annual Meeting 2026 »
Don’t miss the world’s premier cancer research event, April 17 to 22 in San Diego. In-person and virtual registration packages include access to live sessions, Q&A, networking, CME/MOC credits for select sessions within the Educational Program, and more.
